HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,632 | -27.9% | 43,144 | -24.4% | 0.00% | – |
| Q1 2023 | $42,479 | +32.7% | 57,080 | +71.1% | 0.00% | – |
| Q3 2022 | $32,000 | -13.5% | 33,361 | +73.6% | 0.00% | – |
| Q2 2022 | $37,000 | -95.8% | 19,212 | -83.6% | 0.00% | -100.0% |
| Q4 2021 | $887,000 | -72.4% | 117,442 | -71.1% | 0.00% | -71.4% |
| Q3 2021 | $3,211,000 | +556.6% | 406,470 | +1311.4% | 0.01% | +250.0% |
| Q3 2020 | $489,000 | +1.5% | 28,800 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $482,000 | +3.4% | 29,022 | -27.9% | 0.00% | -50.0% |
| Q1 2020 | $466,000 | -20.3% | 40,232 | +1.7% | 0.00% | +100.0% |
| Q4 2019 | $585,000 | – | 39,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |